Clearer Picture of Heparin–Protein Interactions

  • ChemPubSoc Europe Logo
  • Author: Ruben Ragg
  • Published Date: 30 June 2018
  • Source / Publisher: ChemBioChem/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
thumbnail image: Clearer Picture of Heparin–Protein Interactions

Related Societies

Heparin is a highly sulfated glycosaminoglycan of natural origin and is very commonly used as an anticoagulant and antithrombotic drug. Despite its clinical use for a century, the biological properties of heparin are not completely understood. Chemoenzymatic synthesis has provided access to highly tuneable oligosaccharides, which opens up opportunities for characterizing heparin–protein interactions.

Marco Guerrini, Ronzoni Institute, Milan, Italy, and colleagues have studied an example of a new antithrombin-binding heparin oligosaccharide prepared by chemoenzymatic synthesis. The compound can activate the coagulation inhibitor antithrombin despite a lack of 2-O-sulfation at the iduronic acid residue. This is a remarkable finding given that the most common disaccharide in heparin is composed of a 2-O-sulfated iduronic acid and a 6-O-sulfated, N-sulfated glucosamine.

The availability of new oligosaccharide models, coupled with up to date NMR spectroscopy techniques and molecular dynamics (MD) simulations, could contribute a full understanding of the complex physiological role of heparin.


Article Views: 905

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from, please contact us first for permission. more

CONNECT: on Facebook on Twitter on YouTube on LinkedIn Sign up for our free newsletter

A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH